No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Apolipoprotein A1 Infusions do not Improve Cardiovascular Outcomes after Acute Myocardial Infarction

byAstrid BradshawandAlisha Yi

May 7, 2024

in StudyGraphics

Reading Time: 1 min read

Click here to read this study in NEJM.

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

WHO launches 2026 global initiative to bridge the schizophrenia mortality gap

Tenecteplase (TNKase) may worsen functional outcomes in older patients with minor ischemic stroke

Asundexian may reduce recurrent ischemic stroke without increased bleeding risk

Higher national health expenditure correlates with better lymphoid malignancy survival rates in European countries.

RelatedReports

Psychiatry

WHO launches 2026 global initiative to bridge the schizophrenia mortality gap

April 30, 2026

Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults

Neurology

Tenecteplase (TNKase) may worsen functional outcomes in older patients with minor ischemic stroke

April 24, 2026

Abusive head trauma results in fewer productive life-years

Cardiology

Asundexian may reduce recurrent ischemic stroke without increased bleeding risk

April 20, 2026

Neurology

Apolipoprotein E mimetic peptide CN-105 may be safe and feasible for delirium prevention in older surgical patients

April 6, 2026

Topical pimecrolimus use for atopic dermatitis not linked to malignancy

AbbVie: Rinvoq, a monoclonal antibody against JAK enzyme, has superior efficacy in patients with atopic dermatitis compared to Dupixent

Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation

Eli Lilly: Tirzepatide Shows Promise In Treating Obstructive Sleep Apnea In Two Phase 3 Clinical Trials

#VisualAbstract: Recombinant ADAMTS13 Prophylaxis Leads to Rare Thrombotic Thrombocytopenic Purpura Events in Patients with Congenital Thrombotic Thrombocytopenic Purpura

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result